Clinical trial
A Multi-national, Non-interventional Study of Bempedoic Acid or Its Single-pill Combination Therapy With Ezetimibe in Routine Clinical Practice in Patients With Primary Hypercholesterolaemia or Mixed Dyslipidaemia
NCT07206472 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-national, Non-interventional Study of Bempedoic Acid or Its Single-pill Combination Therapy With Ezetimibe in Routine Clinical Practice in Patients With Primary Hypercholesterolaemia or Mixed Dyslipidaemia
- Lead sponsor
- Daiichi Sankyo
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 3, 2026
- Completion date
- December 31, 2028
- Enrollment
- 2,120 (estimated)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.
mixed dyslipidemia, primary hypercholesterolaemia